rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Matthew B. Murphy

General Counsel

Company insider

Files Form 4 as: General Counsel, Nautilus Biotechnology.

In numbers

Trades disclosed
12
Buys
4
Sells
0
Bought
$79K
Sold
$0
Companies
1
Companies where not an officer
0
First trade
14 Jun 2021
Last trade
2 Mar 2026
Last filed
4 Mar 2026

Companies traded

Where they are an officer
NAUT Nautilus BiotechnologyOfficer · Life-science tools · last 2 Mar 20264 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
2 Mar 2026filed 4 Mar 2026NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—160,000 at $0.00filing
2 Mar 2026filed 4 Mar 2026NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—160,000 at $0.00filing
4 Sep 2025filed 5 Sep 2025NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$13K20,000 at $0.64filing
3 Mar 2025filed 4 Mar 2025NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—160,000 at $0.00filing
1 Mar 2024filed 5 Mar 2024NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—160,000 at $0.00filing
27 Feb 2023filed 1 Mar 2023NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—160,000 at $0.00filing
15 Aug 2022filed 16 Aug 2022NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$21K7,500 at $2.84filing
12 Aug 2022filed 16 Aug 2022NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$7,1252,500 at $2.85filing
12 May 2022filed 13 May 2022NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Code A$33K10,000 at $3.28filing
25 Feb 2022filed 25 Feb 2022NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—140,000 at $0.00filing
13 Aug 2021filed 13 Aug 2021NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$38K5,000 at $7.56filing
14 Jun 2021filed 4 Aug 2021NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—326,526 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

Epperly Melissa BDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Farzad NazemDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Karen AkinsanyaOfficer · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Matthew S. McIlwainDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Matthew L. PosardDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year